An investor in NYSE:GI shares filed a lawsuit over alleged violations of Securities Laws by EndoChoice Holdings in connection with the company’s Initial Public Offering.
Investors who purchased shares of EndoChoice Holdings Inc (NYSE:GI) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
EndoChoice Holdings Inc conducted its Initial Public Offering (“IPO”) on or about June 5, 2015 selling 6,350,000 shares of EndoChoice Holdings Inc common stock at a price of $15.00 per share.
The plaintiff claims that that documents issued pursuant to the IPO were materially misleading and/or omitted material facts
On November 5, 2015, EndoChoice Holdings Inc announced a decline in Fuse placements in the third quarter; the Company also announced it had entered into a strategic partnership with De Lage Landen Financial Services, Inc. to provide a new financing program for EndoChoice customers in the United States.
Shares of EndoChoice Holdings Inc (NYSE:GI) declined from $17.07 per share in August 2015 to as low as $3.80 per share in February 2016.
On August 15, 2016, NYSE:GI shares closed at $3.95 per share.
Those who purchased NYSE:GI shares have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com